Brief: Sedana Medical Q2 Sales SEK 41.1 Million
23/07/2024 06:00
Jul 23 (Reuters) - Sedana Medical Q2 net income SEK -17.2 million. * Q2 EBIT margin -46% * Q2 cash flow from operating activities SEK 1.9 million * Q2 adjusted EPS SEK -0.18 * Q2 EBITDA SEK -13.9 million
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln